VAERS ID: 2315244

AGE: 68| SEX: F|STATE: CA

Description

COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient. A 68-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 05Feb2021 at 07:15 as dose 1, single (Lot number: EN6201), in right arm, on 26Feb2021 at 06:45 as dose 2, single (Lot number: EN6201), in right arm, on 27Sep2021 at 17:15 as dose 3 (booster), single (Lot number: FF8839), in right arm and on 06Apr2022 at 17:15 as dose 4 (booster), single (Lot number: FK9895) at the age of 68 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Breast cancer" (unspecified if ongoing); "Known Allergies: Penicillin" (unspecified if ongoing); "Known Allergies: peanut Products" (unspecified if ongoing); "Known Allergies: Oil/Food" (unspecified if ongoing); "Known Allergies: Dust" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Covid Rebound; Positive, notes: Currently day 9 with with positive test. Therapeutic measures were taken as a result of drug ineffective, covid-19. Addition information: Covid Rebound with heavy nasal congestion, sore throat and sneezing on day 8 after 5 day treatment with Paxlovid beginning on day 1 of symptoms/positive test; also nasty metallic taste in mouth days 1-5 while taking Paxlovid. Currently day 9 with positive test and heavy sinus/throat symptoms. Treatment start date was 29May2022. Treatment stop date was 02Jun2022.; Sender's Comments: The reported Covid 19 positive after both the doses of COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported events and BNT162B2 administration.

Symptoms

COVID-19, SARS-CoV-2 test, Vaccination failure

Vaccines

VAX DATE: 04-06-2022| ONSET DATE: | DAYS TO ONSET:
NameDose #TypeManufacturerLotRouteSite
COVID19 (COVID19 (PFIZER-BIONTECH)) 4 COVID19 PFIZER\BIONTECH FK9895 Unknown LA

RECVDATE:06-10-2022
RPT_DATE:
CAGE_YR:
CAGE_MO:
DIED:U
DATEDIED:
L_THREAT:U
ER_VISIT:U
HOSPITAL:U
HOSPDAYS:
X_STAY:U
DISABLE:U
RECOVD:U
LAB_DATA:Test Name: COVID-19 Test; Test Result: Positive ; Comments: Covid Rebound; Test Name: COVID-19 Test; Test Result: Positive ; Comments: Currently day 9 with positive test
V_ADMINBY:
OTHER_MEDS:
CUR_ILL:
HISTORY:Medical History/Concurrent Conditions: Breast cancer; Dust allergy; Food allergy; Peanut allergy; Penicillin allergy
PRIOR_VAX:
SPLTTYPE:USPFIZER INC202200806550
FORM_VERS:2
TODAYS_DATE:06-09-2022
BIRTH_DEFECT:U
OFC_VISIT:U
ER_ED_VISIT:U
ALLERGIES:
V_FUNDBY:

Questions? Comments? Bugs?
[email protected]
Due to the high volume of inquiries, please be patient with response times.

AND PLEASE read the FAQ first.

OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.